25 XP   0   0   10

aap Implantate AG
Buy, Hold or Sell?

Let's analyse Aap together

PenkeI guess you are interested in aap Implantate AG. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of aap Implantate AG. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about aap Implantate AG

I send you an email if I find something interesting about aap Implantate AG.

Quick analysis of Aap (30 sec.)










What can you expect buying and holding a share of Aap? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
€1.30
Expected worth in 1 year
€1.32
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
€0.02
Return On Investment
1.7%

For what price can you sell your share?

Current Price per Share
€1.19
Expected price per share
€0.885 - €1.57
How sure are you?
50%

1. Valuation of Aap (5 min.)




Live pricePrice per Share (EOD)

€1.19

Intrinsic Value Per Share

€-5.93 - €4.97

Total Value Per Share

€-4.63 - €6.27

2. Growth of Aap (5 min.)




Is Aap growing?

Current yearPrevious yearGrowGrow %
How rich?$13.9m$13.8m$55.3k0.4%

How much money is Aap making?

Current yearPrevious yearGrowGrow %
Making money-$2.7m-$2.7m-$45.6k-1.6%
Net Profit Margin-22.3%-20.7%--

How much money comes from the company's main activities?

3. Financial Health of Aap (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

What can you expect buying and holding a share of Aap? (5 min.)

Welcome investor! Aap's management wants to use your money to grow the business. In return you get a share of Aap.

What can you expect buying and holding a share of Aap?

First you should know what it really means to hold a share of Aap. And how you can make/lose money.

Speculation

The Price per Share of Aap is €1.19. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Aap.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Aap, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €1.30. Based on the TTM, the Book Value Change Per Share is €0.01 per quarter. Based on the YOY, the Book Value Change Per Share is €0.25 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Aap.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.28-23.7%-0.28-23.7%-0.28-23.3%-0.91-76.1%-0.75-62.8%
Usd Book Value Change Per Share0.010.5%0.010.5%0.2723.0%-0.65-55.0%-0.42-35.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.2%0.000.1%
Usd Total Gains Per Share0.010.5%0.010.5%0.2723.0%-0.65-54.8%-0.42-35.1%
Usd Price Per Share1.47-1.47-3.26-1.96-1.94-
Price to Earnings Ratio-5.19--5.19--11.73--4.41--8.78-
Price-to-Total Gains Ratio261.08-261.08-11.91-53.54-24.80-
Price to Book Ratio1.04-1.04-2.32-1.38-0.88-
Price-to-Total Gains Ratio261.08-261.08-11.91-53.54-24.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.292578
Number of shares773
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.01-0.65
Usd Total Gains Per Share0.01-0.65
Gains per Quarter (773 shares)4.34-504.10
Gains per Year (773 shares)17.37-2,016.39
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101778-2025-2026
20352417-4050-4042
30524125-6074-6058
40695834-8099-8074
50877542-10124-10090
601049251-12149-12106
7012210959-14174-14122
8013912668-16199-16138
9015614376-18223-18154
10017416084-20248-20170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%6.014.01.028.6%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%3.07.00.030.0%11.010.00.052.4%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%1.00.09.010.0%2.00.019.09.5%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%3.07.00.030.0%11.010.00.052.4%

Fundamentals of Aap

About aap Implantate AG

aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. It offers LOQTEQ, an anatomical plating system for fracture treatment of ankle joint, knee, elbow, and shoulder; and a range of cannulated screws. The company sells its products directly to hospitals, purchasing groups, and hospital groups in Germany, and through a network of distributors internationally. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

Fundamental data was last updated by Penke on 2024-05-13 05:27:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of aap Implantate AG.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Aap earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Aap to the Medical Devices industry mean.
  • A Net Profit Margin of -22.3% means that €-0.22 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of aap Implantate AG:

  • The MRQ is -22.3%. The company is making a huge loss. -2
  • The TTM is -22.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-22.3%TTM-22.3%0.0%
TTM-22.3%YOY-20.7%-1.5%
TTM-22.3%5Y-75.1%+52.8%
5Y-75.1%10Y-37.5%-37.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-22.3%-11.0%-11.3%
TTM-22.3%-16.5%-5.8%
YOY-20.7%-12.3%-8.4%
5Y-75.1%-19.6%-55.5%
10Y-37.5%-23.9%-13.6%
1.1.2. Return on Assets

Shows how efficient Aap is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aap to the Medical Devices industry mean.
  • -12.7% Return on Assets means that Aap generated €-0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of aap Implantate AG:

  • The MRQ is -12.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.7%TTM-12.7%0.0%
TTM-12.7%YOY-11.0%-1.7%
TTM-12.7%5Y-32.2%+19.5%
5Y-32.2%10Y-17.1%-15.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.7%-3.3%-9.4%
TTM-12.7%-4.1%-8.6%
YOY-11.0%-3.6%-7.4%
5Y-32.2%-3.7%-28.5%
10Y-17.1%-4.1%-13.0%
1.1.3. Return on Equity

Shows how efficient Aap is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aap to the Medical Devices industry mean.
  • -20.0% Return on Equity means Aap generated €-0.20 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of aap Implantate AG:

  • The MRQ is -20.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -20.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-20.0%TTM-20.0%0.0%
TTM-20.0%YOY-19.7%-0.2%
TTM-20.0%5Y-50.3%+30.3%
5Y-50.3%10Y-26.6%-23.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.0%-3.7%-16.3%
TTM-20.0%-4.2%-15.8%
YOY-19.7%-4.6%-15.1%
5Y-50.3%-5.6%-44.7%
10Y-26.6%-5.8%-20.8%

1.2. Operating Efficiency of aap Implantate AG.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Aap is operating .

  • Measures how much profit Aap makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aap to the Medical Devices industry mean.
  • An Operating Margin of -28.1% means the company generated €-0.28  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of aap Implantate AG:

  • The MRQ is -28.1%. The company is operating very inefficient. -2
  • The TTM is -28.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-28.1%TTM-28.1%0.0%
TTM-28.1%YOY-22.1%-6.0%
TTM-28.1%5Y-52.8%+24.7%
5Y-52.8%10Y-26.2%-26.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-28.1%-29.1%+1.0%
TTM-28.1%-13.8%-14.3%
YOY-22.1%-12.6%-9.5%
5Y-52.8%-18.5%-34.3%
10Y-26.2%-22.5%-3.7%
1.2.2. Operating Ratio

Measures how efficient Aap is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.29 means that the operating costs are €1.29 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of aap Implantate AG:

  • The MRQ is 1.294. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.294. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.294TTM1.2940.000
TTM1.294YOY1.221+0.073
TTM1.2945Y1.546-0.252
5Y1.54610Y1.508+0.038
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2941.432-0.138
TTM1.2941.429-0.135
YOY1.2211.407-0.186
5Y1.5461.407+0.139
10Y1.5081.371+0.137

1.3. Liquidity of aap Implantate AG.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Aap is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.03 means the company has €2.03 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of aap Implantate AG:

  • The MRQ is 2.026. The company is able to pay all its short-term debts. +1
  • The TTM is 2.026. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.026TTM2.0260.000
TTM2.026YOY2.101-0.076
TTM2.0265Y2.715-0.689
5Y2.71510Y3.732-1.017
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0262.689-0.663
TTM2.0262.724-0.698
YOY2.1013.378-1.277
5Y2.7153.659-0.944
10Y3.7323.670+0.062
1.3.2. Quick Ratio

Measures if Aap is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aap to the Medical Devices industry mean.
  • A Quick Ratio of 0.65 means the company can pay off €0.65 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of aap Implantate AG:

  • The MRQ is 0.647. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.647. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.647TTM0.6470.000
TTM0.647YOY0.924-0.277
TTM0.6475Y1.352-0.705
5Y1.35210Y2.180-0.828
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6471.511-0.864
TTM0.6471.545-0.898
YOY0.9242.092-1.168
5Y1.3522.391-1.039
10Y2.1802.596-0.416

1.4. Solvency of aap Implantate AG.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Aap assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aap to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.37 means that Aap assets are financed with 36.6% credit (debt) and the remaining percentage (100% - 36.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of aap Implantate AG:

  • The MRQ is 0.366. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.366. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.366TTM0.3660.000
TTM0.366YOY0.443-0.078
TTM0.3665Y0.348+0.017
5Y0.34810Y0.278+0.070
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3660.416-0.050
TTM0.3660.400-0.034
YOY0.4430.339+0.104
5Y0.3480.437-0.089
10Y0.2780.454-0.176
1.4.2. Debt to Equity Ratio

Measures if Aap is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aap to the Medical Devices industry mean.
  • A Debt to Equity ratio of 57.7% means that company has €0.58 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of aap Implantate AG:

  • The MRQ is 0.577. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.577. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.577TTM0.5770.000
TTM0.577YOY0.797-0.220
TTM0.5775Y0.578-0.001
5Y0.57810Y0.423+0.156
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5770.591-0.014
TTM0.5770.599-0.022
YOY0.7970.495+0.302
5Y0.5780.637-0.059
10Y0.4230.684-0.261

2. Market Valuation of aap Implantate AG

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Aap generates.

  • Above 15 is considered overpriced but always compare Aap to the Medical Devices industry mean.
  • A PE ratio of -5.19 means the investor is paying €-5.19 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of aap Implantate AG:

  • The EOD is -4.578. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.193. Based on the earnings, the company is expensive. -2
  • The TTM is -5.193. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.578MRQ-5.193+0.615
MRQ-5.193TTM-5.1930.000
TTM-5.193YOY-11.732+6.539
TTM-5.1935Y-4.409-0.784
5Y-4.40910Y-8.781+4.372
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-4.578-1.094-3.484
MRQ-5.193-1.706-3.487
TTM-5.193-2.226-2.967
YOY-11.732-2.651-9.081
5Y-4.409-2.385-2.024
10Y-8.781-2.035-6.746
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of aap Implantate AG:

  • The EOD is -4.936. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.599. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.599. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.936MRQ-5.599+0.664
MRQ-5.599TTM-5.5990.000
TTM-5.599YOY-9.886+4.287
TTM-5.5995Y-4.991-0.608
5Y-4.99110Y-4.769-0.222
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-4.936-2.491-2.445
MRQ-5.599-3.228-2.371
TTM-5.599-2.976-2.623
YOY-9.886-5.572-4.314
5Y-4.991-5.579+0.588
10Y-4.769-5.579+0.810
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Aap is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.04 means the investor is paying €1.04 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of aap Implantate AG:

  • The EOD is 0.915. Based on the equity, the company is cheap. +2
  • The MRQ is 1.038. Based on the equity, the company is underpriced. +1
  • The TTM is 1.038. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.915MRQ1.038-0.123
MRQ1.038TTM1.0380.000
TTM1.038YOY2.316-1.278
TTM1.0385Y1.377-0.339
5Y1.37710Y0.880+0.497
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.9152.048-1.133
MRQ1.0382.303-1.265
TTM1.0382.496-1.458
YOY2.3162.872-0.556
5Y1.3774.072-2.695
10Y0.8804.486-3.606
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of aap Implantate AG compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0050.0050%0.252-98%-0.603+11760%-0.386+7559%
Book Value Per Share--1.3011.3010%1.295+0%1.819-28%3.257-60%
Current Ratio--2.0262.0260%2.101-4%2.715-25%3.732-46%
Debt To Asset Ratio--0.3660.3660%0.443-17%0.348+5%0.278+32%
Debt To Equity Ratio--0.5770.5770%0.797-28%0.5780%0.423+37%
Dividend Per Share----0%-0%0.003-100%0.001-100%
Eps---0.260-0.2600%-0.256-2%-0.834+221%-0.688+165%
Free Cash Flow Per Share---0.241-0.2410%-0.303+26%-0.507+110%-0.522+117%
Free Cash Flow To Equity Per Share---0.193-0.1930%0.055-453%-0.309+60%-0.548+184%
Gross Profit Margin--1.7831.7830%1.740+2%1.409+27%1.778+0%
Intrinsic Value_10Y_max--4.968--------
Intrinsic Value_10Y_min---5.928--------
Intrinsic Value_1Y_max---0.144--------
Intrinsic Value_1Y_min---0.546--------
Intrinsic Value_3Y_max--0.057--------
Intrinsic Value_3Y_min---1.691--------
Intrinsic Value_5Y_max--0.847--------
Intrinsic Value_5Y_min---2.885--------
Market Cap11737112.800-13%13315212.00013315212.0000%29589360.000-55%17757561.248-25%17633384.567-24%
Net Profit Margin---0.223-0.2230%-0.207-7%-0.751+237%-0.375+68%
Operating Margin---0.281-0.2810%-0.221-21%-0.528+88%-0.262-7%
Operating Ratio--1.2941.2940%1.221+6%1.546-16%1.508-14%
Pb Ratio0.915-13%1.0381.0380%2.316-55%1.377-25%0.880+18%
Pe Ratio-4.578+12%-5.193-5.1930%-11.732+126%-4.409-15%-8.781+69%
Price Per Share1.190-13%1.3501.3500%3.000-55%1.800-25%1.788-24%
Price To Free Cash Flow Ratio-4.936+12%-5.599-5.5990%-9.886+77%-4.991-11%-4.769-15%
Price To Total Gains Ratio230.139-13%261.083261.0830%11.912+2092%53.537+388%24.797+953%
Quick Ratio--0.6470.6470%0.924-30%1.352-52%2.180-70%
Return On Assets---0.127-0.1270%-0.110-13%-0.322+154%-0.171+35%
Return On Equity---0.200-0.2000%-0.197-1%-0.503+152%-0.266+33%
Total Gains Per Share--0.0050.0050%0.252-98%-0.600+11711%-0.384+7534%
Usd Book Value--13932687.40013932687.4000%13877291.200+0%19482734.920-28%34888635.380-60%
Usd Book Value Change Per Share--0.0060.0060%0.274-98%-0.655+11760%-0.419+7559%
Usd Book Value Per Share--1.4131.4130%1.407+0%1.975-28%3.537-60%
Usd Dividend Per Share----0%-0%0.003-100%0.001-100%
Usd Eps---0.282-0.2820%-0.278-2%-0.906+221%-0.747+165%
Usd Free Cash Flow---2582983.600-2582983.6000%-3250996.600+26%-5430565.520+110%-5594038.620+117%
Usd Free Cash Flow Per Share---0.262-0.2620%-0.330+26%-0.551+110%-0.567+117%
Usd Free Cash Flow To Equity Per Share---0.210-0.2100%0.059-453%-0.336+60%-0.595+184%
Usd Market Cap12748851.923-13%14462983.27414462983.2740%32139962.832-55%19288263.028-25%19153382.317-24%
Usd Price Per Share1.293-13%1.4661.4660%3.259-55%1.956-25%1.942-24%
Usd Profit---2785016.800-2785016.8000%-2739396.400-2%-8934646.720+221%-4776238.640+71%
Usd Revenue--12508679.20012508679.2000%13214709.200-5%12062902.720+4%15997770.840-22%
Usd Total Gains Per Share--0.0060.0060%0.274-98%-0.652+11711%-0.418+7534%
 EOD+2 -6MRQTTM+0 -0YOY+12 -225Y+25 -1110Y+20 -16

3.2. Fundamental Score

Let's check the fundamental score of aap Implantate AG based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.578
Price to Book Ratio (EOD)Between0-10.915
Net Profit Margin (MRQ)Greater than0-0.223
Operating Margin (MRQ)Greater than0-0.281
Quick Ratio (MRQ)Greater than10.647
Current Ratio (MRQ)Greater than12.026
Debt to Asset Ratio (MRQ)Less than10.366
Debt to Equity Ratio (MRQ)Less than10.577
Return on Equity (MRQ)Greater than0.15-0.200
Return on Assets (MRQ)Greater than0.05-0.127
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of aap Implantate AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.752
Ma 20Greater thanMa 501.282
Ma 50Greater thanMa 1000.987
Ma 100Greater thanMa 2000.880
OpenGreater thanClose1.230
Total5/5 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets20,228
Total Liabilities7,401
Total Stockholder Equity12,827
 As reported
Total Liabilities 7,401
Total Stockholder Equity+ 12,827
Total Assets = 20,228

Assets

Total Assets20,228
Total Current Assets11,181
Long-term Assets9,047
Total Current Assets
Cash And Cash Equivalents 236
Short-term Investments 268
Net Receivables 2,800
Inventory 7,819
Other Current Assets 58
Total Current Assets  (as reported)11,181
Total Current Assets  (calculated)11,181
+/-0
Long-term Assets
Property Plant Equipment 4,352
Intangible Assets 2,110
Long-term Assets Other 269
Long-term Assets  (as reported)9,047
Long-term Assets  (calculated)6,731
+/- 2,316

Liabilities & Shareholders' Equity

Total Current Liabilities5,520
Long-term Liabilities1,881
Total Stockholder Equity12,827
Total Current Liabilities
Short-term Debt 2,004
Short Long Term Debt 487
Accounts payable 2,116
Other Current Liabilities 1,400
Total Current Liabilities  (as reported)5,520
Total Current Liabilities  (calculated)6,007
+/- 487
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt781
Long-term Liabilities Other 209
Long-term Liabilities  (as reported)1,881
Long-term Liabilities  (calculated)990
+/- 891
Total Stockholder Equity
Common Stock6,571
Retained Earnings -19,709
Other Stockholders Equity 25,965
Total Stockholder Equity (as reported)12,827
Total Stockholder Equity (calculated)12,827
+/-0
Other
Capital Stock6,571
Cash and Short Term Investments 504
Common Stock Shares Outstanding 5,956
Liabilities and Stockholders Equity 20,228
Net Debt 3,036
Net Invested Capital 13,314
Net Working Capital 5,661
Property Plant and Equipment Gross 14,301
Short Long Term Debt Total 3,272



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-31
> Total Assets 
4,159,800
2,670,275
20,448
25,081
27,554
68,018
67,030
62,655
63,632
66,151
68,590
65,237
57,857
54,946
63,850
50,469
42,221
26,288
19,706
22,954
20,228
20,22822,95419,70626,28842,22150,46963,85054,94657,85765,23768,59066,15163,63262,65567,03068,01827,55425,08120,4482,670,2754,159,800
   > Total Current Assets 
1,359,300
1,004,314
9,687
10,947
12,766
10,774
22,537
21,589
21,035
22,476
23,669
42,843
32,839
35,743
41,782
28,766
19,727
13,951
10,527
13,317
11,181
11,18113,31710,52713,95119,72728,76641,78235,74332,83942,84323,66922,47621,03521,58922,53710,77412,76610,9479,6871,004,3141,359,300
       Cash And Cash Equivalents 
0
0
1,182
1,384
2,069
297
96
2,406
909
2,152
3,698
1,580
12,165
4,941
23,774
13,279
4,260
2,934
885
2,112
236
2362,1128852,9344,26013,27923,7744,94112,1651,5803,6982,1529092,406962972,0691,3841,18200
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
1,120
597
616
169
3,666
3,001
2,850
1,267
292
191
268
2681912921,2672,8503,0013,6661696165971,1200000000000
       Net Receivables 
0
0
3,450
1,524
0
0
6,796
6,007
6,221
5,508
4,226
7,147
10,756
5,930
1,539
2,709
3,033
2,066
2,147
3,359
2,800
2,8003,3592,1472,0663,0332,7091,5395,93010,7567,1474,2265,5086,2216,0076,796001,5243,45000
       Inventory 
821,400
677,946
5,953
6,925
7,170
10,477
13,714
11,538
12,688
13,991
13,849
9,342
9,301
9,656
11,001
9,574
9,583
7,681
6,953
7,312
7,819
7,8197,3126,9537,6819,5839,57411,0019,6569,3019,34213,84913,99112,68811,53813,71410,4777,1706,9255,953677,946821,400
       Other Current Assets 
199,700
-110,148
-899
1,114
3,527
0
1,931
1,638
1,217
825
5,002
31,324
1
20,977
1,802
2,912
1
1,267
292
343
58
583432921,26712,9121,80220,977131,3245,0028251,2171,6381,93103,5271,114-899-110,148199,700
   > Long-term Assets 
2,800,500
1,665,961
10,761
14,134
14,788
48,017
44,493
41,066
42,597
43,675
44,921
22,394
25,017
19,203
20,267
21,704
22,493
12,337
9,179
9,636
9,047
9,0479,6369,17912,33722,49321,70420,26719,20325,01722,39444,92143,67542,59741,06644,49348,01714,78814,13410,7611,665,9612,800,500
       Property Plant Equipment 
901,700
747,832
3,398
3,785
1,763
6,796
7,309
5,055
5,200
5,071
5,107
5,906
7,690
7,674
7,616
7,197
6,877
7,116
4,698
5,253
4,352
4,3525,2534,6987,1166,8777,1977,6167,6747,6905,9065,1075,0715,2005,0557,3096,7961,7633,7853,398747,832901,700
       Goodwill 
336,200
0
0
1,568
0
13,057
13,057
12,490
12,490
12,490
12,490
1,568
1,568
0
0
0
0
0
0
0
0
000000001,5681,56812,49012,49012,49012,49013,05713,05701,56800336,200
       Intangible Assets 
1,666,500
871,491
4,675
6,017
0
25,441
21,449
23,038
24,510
25,758
26,914
12,934
13,630
10,442
11,146
11,848
13,286
1,865
2,573
2,315
2,110
2,1102,3152,5731,86513,28611,84811,14610,44213,63012,93426,91425,75824,51023,03821,44925,44106,0174,675871,4911,666,500
       Long-term Assets Other 
-103,900
46,638
2,688
388
4,291
-48,017
358
356
356
356
-1
767
1,077
479
1,863
2,998
2,848
2,582
291
189
269
2691892912,5822,8482,9981,8634791,077767-1356356356358-48,0174,2913882,68846,638-103,900
> Total Liabilities 
1,988,500
2,042,924
4,915
5,715
6,425
24,571
25,727
17,940
18,780
17,801
17,724
16,786
12,433
14,639
9,075
7,910
7,302
7,419
9,414
10,178
7,401
7,40110,1789,4147,4197,3027,9109,07514,63912,43316,78617,72417,80118,78017,94025,72724,5716,4255,7154,9152,042,9241,988,500
   > Total Current Liabilities 
1,374,400
1,269,940
4,592
4,407
0
13,780
16,334
13,596
14,986
15,126
13,018
13,671
7,452
11,233
5,643
5,121
4,671
4,466
5,015
6,337
5,520
5,5206,3375,0154,4664,6715,1215,64311,2337,45213,67113,01815,12614,98613,59616,33413,78004,4074,5921,269,9401,374,400
       Short-term Debt 
31,800
22,067
892
0
0
302
7,897
5,740
0
0
130
2,744
2,061
3,586
1,520
1,456
326
777
975
2,904
2,004
2,0042,9049757773261,4561,5203,5862,0612,744130005,7407,8973020089222,06731,800
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
999
0
0
0
175
1,462
487
4871,46217500099900000000000000
       Accounts payable 
186,000
227,665
1,308
925
0
2,398
3,218
1,799
2,967
3,120
3,259
2,853
2,949
4,102
2,541
1,752
2,149
1,460
1,973
2,366
2,116
2,1162,3661,9731,4602,1491,7522,5414,1022,9492,8533,2593,1202,9671,7993,2182,39809251,308227,665186,000
       Other Current Liabilities 
197,600
355,084
1,488
3,482
0
3,842
4,836
5,860
12,019
12,006
115
138
138
97
95
94
2,099
93
330
64
1,400
1,40064330932,09994959713813811512,00612,0195,8604,8363,84203,4821,488355,084197,600
   > Long-term Liabilities 
614,100
772,983
322
1,308
0
10,791
9,393
4,344
3,794
2,675
4,706
3,115
4,981
3,406
3,432
2,789
2,631
2,953
4,399
3,841
1,881
1,8813,8414,3992,9532,6312,7893,4323,4064,9813,1154,7062,6753,7944,3449,39310,79101,308322772,983614,100
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,122
2,155
2,328
1,184
1,011
910
0
09101,0111,1842,3282,1552,12200000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,013
11,740
13,069
3,063
2,524
2,244
0
02,2442,5243,06313,06911,74011,01300000000000000
> Total Stockholder Equity
2,171,300
627,351
15,533
19,366
21,129
43,447
41,175
44,586
44,719
48,353
50,866
48,451
45,424
40,307
54,775
42,559
34,919
18,869
10,292
12,776
12,827
12,82712,77610,29218,86934,91942,55954,77540,30745,42448,45150,86648,35344,71944,58641,17543,44721,12919,36615,533627,3512,171,300
   Common Stock
476,400
486,953
14,609
16,519
0
25,347
26,614
27,882
27,882
30,670
30,670
30,670
30,670
30,670
30,832
28,644
28,707
32,067
3,207
4,978
6,571
6,5714,9783,20732,06728,70728,64430,83230,67030,67030,67030,67030,67027,88227,88226,61425,347016,51914,609486,953476,400
   Retained Earnings Total Equity000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
19,258
18,099
887
15,169
12,057
-25,521
-45,041
-26,172
-28,871
-31,554
-31,554-28,871-26,172-45,041-25,52112,05715,16988718,09919,25800000000000
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
1,694,900
140,398
24,394
26,123
19,589
18,100
40,511
40,718
16,837
41,258
19,219
228
228
17,386
17,510
19,865
31,885
20,138
21,709
24,943
25,965
25,96524,94321,70920,13831,88519,86517,51017,38622822819,21941,25816,83740,71840,51118,10019,58926,12324,394140,3981,694,900



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.